Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
56.40
-0.20 (-0.35%)
Aug 28, 2026, 1:30 PM CST
TPE:1720 Market Cap
TPE:1720 has a market cap or net worth of 10.08 billion as of August 28, 2026.
Market Cap
10.08B
Enterprise Value
11.68B
Revenue
7.08B
Ranking
n/a
PE Ratio
10.83
Stock Price
56.40
ChartMarket Cap Chart
Since March 4, 1996, TPE:1720's market cap has increased from 2.29B to 10.08B, an increase of 339.34%. That is a compound annual growth rate of 4.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 10.08B | -4.24% |
| Dec 31, 2025 | 10.53B | -4.85% |
| Dec 31, 2024 | 11.06B | -6.07% |
| Dec 29, 2023 | 11.78B | 7.15% |
| Dec 30, 2022 | 10.99B | 42.69% |
| Dec 30, 2021 | 7.70B | 14.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TTY Biopharm Company | 19.44B |
| Synmosa Biopharma | 16.14B |
| ScinoPharm Taiwan | 15.06B |
| YungShin Global Holding | 14.86B |
| Grape King Bio | 13.36B |
| Foresee Pharmaceuticals | 12.63B |
| Handa Pharmaceuticals | 12.62B |
| Alar Pharmaceuticals | 6.63B |